Purchases and Sales Made in Q4 2024 in Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL) during Q4 2024. The information is specifically focused on institutions that hold shares of Achilles Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
40.4K+ 190.07% |
$38.8K - $47.7K
|
61.6K
$85.1K
|
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
26.8KNew |
$25.8K - $31.7K
|
26.8K
$37K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
17.3K+ 105.29% |
$16.6K - $20.4K
|
33.7K
$46.5K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
15.8KNew |
$15.2K - $18.6K
|
15.8K
$21.8K
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
11.8K+ 52.68% |
$11.3K - $13.9K
|
34.2K
$47.2K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
322New |
$309 - $380
|
322
$444
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-2.04K- 0.49% |
$1.96K - $2.41K
|
418K
$577K
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-2.04K- 0.14% |
$1.96K - $2.41K
|
1.44M
$1.99M
|
|
|
Feb 11, 2025
Q4 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-59K- 23.52% |
$56.6K - $69.6K
|
192K
$265K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-90.9K- 14.24% |
$87.3K - $107K
|
547K
$755K
|